Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-12-02 00:00:00 ET · period of report 2022-11-30 · accession 0001415889-22-011982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-02 | 2022-11-30 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +85 | 2,045 | +4% | +$181.90 |
| D | 2022-12-02 | 2022-11-30 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.06 | -85 | 1,960 | -4% | -$1,620 |
| D | 2022-12-02 | 2022-11-30 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -85 | 96.3K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-30 | M | A | 85 | $2.14 | 2,045 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-30 | S | D | 85 | $19.06 | 1,960 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-11-30 | M | D | 85 | $0.00 | 96,293 | D | $2.14 · — to 2031-04-01 | 85 Common Stock | (F3) A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |